检验医学 ›› 2012, Vol. 27 ›› Issue (1): 44-47.

• 生物化学检验论著 • 上一篇    下一篇

肝硬化患者消化道状态与血氨的关系研究

  

  1. 1.四川大学华西医院实验医学科,四川 成都 610041; 2.四川大学华西医院消化内科,四川 成都 610041
  • 收稿日期:2011-04-25 出版日期:2012-01-20 发布日期:2012-01-20
  • 通讯作者: 李贵星,联系电话:028-85422615。
  • 作者简介:贺 勇,女,1982年生,硕士,主要从事疾病发生发展的生化机理与诊断方法的研究。

The relationship of gastrointestinal state and plasma ammonia in cirrhosis patients

  1. 1.Department of Laboratory Medicine, West China Hospital , Sichuan University, Sichuan Chengdu 610041,China; 2.Department of Digestion Medicine, West China Hospital, Sichuan University, Sichuan Chengdu 610041,China
  • Received:2011-04-25 Online:2012-01-20 Published:2012-01-20

摘要: 目的  研究肝硬化伴消化道功能障碍患者酸化肠道治疗前、后的血氨水平变化,探讨肝硬化患者消化道状态与血氨水平的关系,寻找减少肠道氨吸收的有效方法,达到降低血氨的目的。方法  测定195例肝硬化患者(包括单纯性肝硬化患者100例、肝硬化伴消化道出血患者52例、肝硬化伴便秘患者43例)、50例单纯性肠梗阻患者、113例单纯性消化道出血患者及80名正常对照者的空腹血氨水平。比较各组血氨水平,研究肝硬化伴消化道出血或(和)便秘患者酸化肠道治疗前、后的血氨水平变化。结果  肝硬化伴消化道出血组血氨水平为(67.71±30.31) μmol/L,高于单纯性肝硬化组[(45.81±28.78) μmol/L]、单纯性消化道出血组 [(  24.85±10.79) μmol/L]和正常对照组[(22.42±7.93) μmol/L](P<0.05)。肝硬化伴便秘组血氨水平为(95.53±  42.61) μmol/L,高于单纯性肝硬化组、肝硬化伴消化道出血组和单纯性肠梗阻组[(24.90±11.02) μmol/L](P<0.05)。单纯性肝硬化组血氨水平高于单纯性消化道出血、单纯性肠梗阻组及正常对照组(P<0.05);而单纯性消化道出血、单纯性肠梗阻组与正常对照组比较差异无统计学意义(P>0.05)。肝硬化伴消化道出血或(和)便秘组治疗前血氨水平为(83.28±37.93) μmol/L,明显高于经酸化肠道治疗后的血氨水平[(50.89±  19.58) μmol/L](P<0.05)。结论  肝硬化患者消化道状态与血氨水平关系密切;阻止消化道出血、酸化肠道及使用抗生素可抑制肠道中氨的产生和吸收,从而降低血氨水平,预防和治疗肝性脑病。

关键词: 血氨, 肝硬化, 消化道出血, 便秘

Abstract: Objective To study the changes on plasma ammonia among cirrhosis patients who had gastrointestinal symptoms before and after acidification intestinal treatment, investigate the relationship of gastrointestinal state and plasma ammonia among cirrhosis patients, and find an effective method to reduce plasma ammonia.   Methods The fast plasma ammonia levels were detected among 195 cirrhosis patients (including 100 patients with just cirrhosis, 52 cirrhosis patients with gastrointestinal hemorrhage and 43 cirrhosis patients with constipation), 50 patients with just intestinal obstruction, 113 patients with just gastrointestinal hemorrhage and 80 healthy subjects. The plasma ammonia levels were compared, and the changes on plasma ammonia levels before and after acidification intestinal treatment were analyzed in cirrhosis patients with gastrointestinal hemorrhage and (or) constipation.  Results Plasma ammonia level among cirrhosis patients with gastrointestinal hemorrhage was (67.71±30.31) μmol/L, which was higher than those of patients with just cirrhosis [(45.81±28.78) μmol/L], patients with just gastrointestinal hemorrhage [(24.85±  10.79) μmol/L] and the healthy controls [(22.42±7.93) μmol/L] (P<0.05). The plasma ammonia level of cirrhosis patients with constipation was (95.53±42.61) μmol/L, which was higher than those of patients with just cirrhosis, cirrhosis patients with gastrointestinal hemorrhage and patients with just intestinal obstruction [(24.90±  11.02) μmol/L] (P<0.05). The plasma ammonia level of patients with just cirrhosis were higher than those of patients with just gastrointestinal hemorrhage, patients with just intestinal obstruction and healthy subjects (P<0.05), while the plasma ammonia levels among patients with just intestinal gastrointestinal hemorrhage, patients with just obstruction and the healthy subjects showed no significant difference (P>0.05). The plasma ammonia levels of cirrhosis patients with gastrointestinal hemorrhage and (or) constipation before the treatment was (83.28±  37.93) μmol/L, which was higher than the level after the treatment [(50.89±19.58) μmol/L] (P<0.05).  Conclusions Gastrointestinal state is closely related with plasma ammonia levels in cirrhosis patients. Stopping gastrointestinal hemorrhage, acidizing gut and using antibiotic drugs could inhibit the production and absorption of ammonia, and those are effective ways to reduce plasma ammonia levels and to prevent and treat hepatic encephalopathy.

Key words: Plasma ammonia, Cirrhosis, Gastrointestinal hemorrhage, Constipation